TAMPA, Fla. (AP) — TAMPA, Fla. (AP) — Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported fourth-quarter profit of $16 million.
On a per-share basis, the Tampa, Florida-based company said it had profit of 34 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to 91 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 86 cents per share.
The specialty drugmaker posted revenue of $187.3 million in the period.
For the year, the company reported a loss of $99.6 million, or $2.15 per share. Revenue was reported as $701 million.
Pacira expects full-year revenue in the range of $725 million to $765 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PCRX at https://www.zacks.com/ap/PCRX
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.